Sterol Regulatory Element Binding Protein 2

Publication Title: 
Cell Reports

The NAD(+)-dependent protein deacetylase SIRT6 regulates genome stability, cancer, and lifespan. Mice overexpressing SIRT6 (MOSES) have lower low-density lipoprotein cholesterol levels and are protected against the physiological damage of obesity. Here, we examined the role of SIRT6 in cholesterol regulation via the lipogenic transcription factors SREBP1 and SREBP2, and AMP-activated protein kinase (AMPK). We show that SIRT6 represses SREBP1 and SREBP2 by at least three mechanisms. First, SIRT6 represses the transcription levels of SREBP1/SREBP2 and that of their target genes.

Author(s): 
Elhanati, Sivan
Kanfi, Yariv
Varvak, Alexander
Roichman, Asael
Carmel-Gross, Ilana
Barth, Shaul
Gibor, Gilad
Cohen, Haim Y.
Publication Title: 
The Journal of Nutrition

Soy intake reduces cholesterol levels. However, both the identity of the soy component or components that contribute to this reduction and the cellular mechanism producing this reduction are unknown. Soy consists of protein, lipids, fiber, and phytochemicals including isoflavones. We propose that the isoflavone component of soy mediates this effect, at least in part, by affecting cellular sterol homeostasis.

Author(s): 
Mullen, Eimear
Brown, Rachel M.
Osborne, Timothy F.
Shay, Neil F.
Publication Title: 
Journal of Lipid Research

We investigated the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in the resistance of dyslipidemic hamsters to statin-induced LDL-cholesterol (LDL-C) reduction and the molecular mechanism by which statins modulated PCSK9 gene expression in vivo. We utilized the fructose diet-induced dyslipidemic hamsters as an in vivo model and rosuvastatin to examine its effects on liver PCSK9 and LDL receptor (LDLR) expression and serum lipid levels. We showed that rosuvastatin induced PCSK9 mRNA to a greater extent than LDLR mRNA in the hamster liver.

Author(s): 
Dong, Bin
Wu, Minhao
Li, Hai
Kraemer, Fredric B.
Adeli, Khosrow
Seidah, Nabil G.
Park, Sahng Wook
Liu, Jingwen
Publication Title: 
Physiological Genomics

Obstructive sleep apnea (OSA), a condition leading to intermittent hypoxia (IH) during sleep, has been associated with dyslipidemia, atherosclerosis, and increased cardiovascular mortality. We previously showed in C57BL/6J mice that IH causes hypercholesterolemia and upregulation of sterol regulatory element binding protein (SREBP)-1, a transcription factor of lipid biosynthesis in the liver. The goal of the present study was to provide mechanistic evidence that IH causes hypercholesterolemia via the SREBP-1 pathway.

Author(s): 
Li, Jianguo
Nanayakkara, Ashika
Jun, Jonathan
Savransky, Vladimir
Polotsky, Vsevolod Y.
Subscribe to RSS - Sterol Regulatory Element Binding Protein 2